Autolytic Activity and Plasma Binding Study of Aap, a Novel Minor Autolysin of Streptococcus pneumoniae

Ramina Mahboobi1, Davoud Afshar1, Mohammad Reza Pourmand1

  • 1Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Acta Medica Iranica
|April 25, 2016
PubMed

Insights

This study identifies Spr1754 from Streptococcus pneumoniae as a novel bifunctional autolysin and lactoferrin-binding protein, named Aap. Further research is needed to fully characterize this pneumococcus protein.

Area of Science:

  • Microbiology
  • Enzymology
  • Protein Biochemistry

Background:

  • Pneumococcal autolysins are crucial for cell wall dynamics and pathogenesis.
  • Understanding novel autolysins aids in developing therapeutic strategies against Streptococcus pneumoniae infections.

Purpose of the Study:

  • To investigate the autolytic activity of the novel protein Spr1754 from Streptococcus pneumoniae.
  • To determine the binding capacity of the recombinant Spr1754 protein to plasma proteins.

Main Methods:

  • Gene amplification (PCR) and cloning of spr1754 into a prokaryotic expression vector.
  • Overexpression in E. coli Origami (DE3) and purification via Ni-NTA affinity chromatography.
  • Assessment of autolytic activity using zymography and plasma protein binding via Western blot.

Main Results:

  • Successful cloning, overexpression, and purification of the recombinant Spr1754 protein.
  • Demonstration of autolytic activity of Spr1754 via zymography.
  • Identification of lactoferrin binding to the recombinant Spr1754 protein, suggesting a bifunctional role.

Conclusions:

  • The novel protein Spr1754 exhibits bifunctional activity as an autolysin and a lactoferrin-binding protein, designated Aap (autolytic/adhesion/pneumococcus).
  • Further studies involving gene inactivation and cell wall localization are required for comprehensive characterization of Aap.